+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID06881992

Evaluation of Ersodetug Added to Standard Care for Treating Hypoglycemia in Patients With Tumor Hyperinsulinism

Led by Rezolute · Updated on 2026-09-28

16

Participants Needed

13

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the glycemic efficacy, safety, and tolerability of ersodetug as an add-on treatment to standard care for patients with Tumor Hyperinsulinism Tumor HI, a condition causing low blood sugar due to hormone overproduction by certain non-removable tumors. This study focuses on patients whose hypoglycemia is not well controlled by existing therapies. It is a Phase 3, single-arm, open-label trial conducted across multiple sites in several countries. Participants will receive weekly doses of ersodetug at 9 mgkg for 8 weeks alongside their usual hypoglycemia treatments. The study has three periods an initial screening lasting up to 4 weeks, the 8-week treatment phase, and then either an end-of-study follow-up of about 20 weeks or an optional open-label extension lasting up to 3 years. The trial plans to enroll approximately 16 participants diagnosed with insulin- or IGF-producing tumors causing tumor HI. During the study, participants will be closely monitored with assessments of glucose infusion rates and other measures related to hypoglycemia control. Researchers will track changes in daily glucose infusion amounts and the time needed to stop intravenous glucose after starting ersodetug. Safety and tolerability will also be evaluated throughout the trial and follow-up periods. The total duration of participation could extend up to several years for those opting into the extension phase.

CONDITIONS

Brief Title

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Research Team

R

Rezolute Clinical Trial

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here